Area of research
Endocrinology, Diabetes and Metabolism · Epidemiology
Research interest
Research interests include Diabetes Treatment and Management, Liver Disease Diagnosis and Treatment, Pancreatic function and diabetes, and Metabolism, Diabetes, and Cancer.
Views and understanding of metabolic dysfunction-associated steatotic liver disease in patients with diabetes
Diabetes management in people undergoing metabolic‐bariatric surgery: A guideline from the Joint British Diabetes Societies for Inpatient Care ( <scp>JBDS</scp> ‐ <scp>IP</scp> ) Group
Assessing glycaemic impact of FreeStyle libre monitoring in patients with insulin-treated type 2 diabetes: a retrospective real-world analysis
Does the short-term use of continuous glucose monitoring enhance diabetes self-management behaviour in type 2 diabetes? The DISCO GM Study: A randomised, controlled cross-over study
The Use of Non-invasive Biomarkers to Screen for Advanced Fibrosis Associated with Metabolic Dysfunction-associated Steatotic Liver Disease in People with Type 2 Diabetes: A Narrative Review
Reversible coagulopathy associated with vitamin E excess
Perioperative Screening for Metabolic Dysfunction Associated Steatotic Liver Disease in People Undergoing Bariatric Surgery: A Pilot Study
The effect of sodium‐glucose cotransporter‐2 inhibitors on inflammatory biomarkers: A meta‐analysis of randomized controlled trials
Changes in Cognitive Function Following Bariatric Surgery: An Updated Systematic Review
Starvation ketoacidosis on the acute medical take: an easily missed complication of the keto diet
The Bidirectional Relationship Between Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study
P330 The real-world impact of treatments for type 2 diabetes on outcomes in people with non-alcoholic fatty liver disease
P323 Routine screening for steatotic liver disease in people with diabetes: a patient survey
P375 The accuracy of non-invasive tests for advanced hepatic fibrosis associated with metabolic dysfunction-associated steatotic liver disease in type 2 diabetes
P351 The impact of increased body mass on non-invasive test accuracy for advanced hepatic fibrosis with metabolic dysfunction-associated steatotic liver disease
Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: A real-world national cohort analysis
Diabetes management in older adults who fall: a study amongst older adults presenting to the emergency department
Benefits in routinely measured liver function tests following bariatric surgery: a retrospective cohort study
Freestyle libre use in people with type 2 diabetes using basal-bolus insulin is associated with improved glycaemic control: A real-world analysis
1474 DIABETES MANAGEMENT IN OLDER ADULTS WHO FALL: A RETROSPECTIVE COHORT STUDY
Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations
Dove Medical Press (Taylor and Francis Group) 2022cited by 102position: last
A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
Diabetes mellitus: what the neurologists need to know
Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?
Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]
DOAJ (DOAJ: Directory of Open Access Journals) 2022cited by 0position: last
Gut microbiota influence in type 2 diabetes mellitus (T2DM)
<scp>Glucagon‐like peptide‐1 receptor agonists</scp> improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study
A physician's approach and experience of managing patients with diabetes during <scp>COVID</scp>‐19
COVID-19 outcomes in people with diabetes in Wales: a secondary analysis of the ABCD audit